A B S T R A C T Preparations of right ventricular papillary muscle and false tendon (Purkinje fiber) were obtained from dog hearts, placed in a bath perfused with Tyrode solution, and observed both under control conditions and during exposure to lidocaine in concentrations from 1 X 10-7 to 5 X 10-' mole/liter. Transmembrane voltages were recorded from both ventricular muscle (VM) and Purkinje fibers (PF) of spontaneously beating and electrically driven preparations. Low concentrations (1 X 10' and 1 X 10' mole/liter) attenuated or abolished phase 4 (diastolic) depolarization and spontaneous firing in PF without decreasing their diastolic excitability. Concentrations of 1 X 10' mole/ liter produced maximal shortening of both action potential duration (APD) and effective refractory period (ERP) and made the ERP long relative to APD; the latter alteration was more prominent in VM. At concentrations < 1 X 10' mole/liter, lidocaine either caused a slight increase or no change in peak maximum rate of phase 0 depolarization (Vrax) and membrane responsiveness, the relationship between transmembrane activation voltage (MAV) 
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INTRODUCTION
Lidocaine hydrochloride has been used sporadically as a cardiac antiarrhythmic drug since 1950 (1) and in the past few years, has been frequently used to treat ventricular arrhythmias which occur during and after cardiac surgery (2) (3) (4) (5) and myocardial infarction (6) (7) (8) (9) . The antiarrhythmic and electrophysiological properties of lidocaine were assumed to be similar to those of procaine amide. This assumption is not unreasonable when one considers the similarity of structure and of local anesthetic properties shared by these two drugs. Indeed, the strongest arguments made for the clinical use of lidocaine in the treatment of arrhythmias rather than procaine amide or quinidine usually have been related to either the pronounced differences in its mode and rate of metabolism (4) (5) (6) (7) (8) or to differences between the effects of lidocaine and these two drugs on blood pressure, cardiac output, and myocardial contractility (9) (10) (11) (12) . Differences in electrophysiological properties or antiarrhythmic spectrum usually have been neglected in such discussions.
However, recent reports suggest significant differences between antiarrhythmic and electrophysiological properties of lidocaine and procaine amide or quinidine (13) . For instance, lidocaine, at therapeutic levels, seems to have less effect on excitability and intraventricular conduction than procaine amide or quinidine (14) . Lidocaine is more effective against arrhythmias induced by digitalis (7, (15) (16) (17) and less effective against atrial arrhythmias such as atrial fibrillation or flutter than procaine amide or quinidine (6) (7) (8) (9) . These observations are sufficient to question the hypothesis that the electroThe Journal of Clinical Investigation Volume 49 1970 physiological properties of lidocaine are identical with or very similar to those of procaine amide or quinidine.
As pointed out previously (18) (19) (20) , ventricular arrhythmias are best understood in terms of alterations in automaticity, conductivity, and the associated changes in the electrophysiological properties of the Purkinje fiber. Automatic ventricular rhythms almost certainly originate in the Purkinje fibers (PF) and the impulse in reentrant ventricular arrhythmias frequently must utilize these fibers as a portion of the reentrant circuit. With these considerations in mind, a study was undertaken to evaluate the effects of lidocaine hydrochloride on the transmembrane potentials of isolated perfused canine Purkinje and ventricular muscle (VM) fibers. The results obtained are compared with those previously reported from studies of the action of procaine amide or quinidine in the same cell types of this same species (21) and used as the basis for speculation about the mechanism of action of lidocaine as a clinical antiarrhythmic agent.
METHODS
Mongrel dogs weighing 10-15 kg were anesthetized with sodium pentobarbital (30 mg/kg, intravenously). The heart was rapidly removed and dissected in cool oxygenated Tyrode solution. False tendon (Purkinje fiber) preparations were dissected from either ventricle, leaving the adjacent Septum Papillary ( 0 FIGURE 1 A diagram of the typical experimental arrangement. The free-running false tendon (Purkinje fibers) is shown as the black strand between a portion of interventricular septum (left) and a portion of papillary muscle (right). A pair of silver extracellular electrodes (1) was placed on the surface of the papillary muscle and used for stimulation. Another pair of silver extracellular electrodes (2) was placed on the surface of the false tendon, 10-15 mm distance from the papillary muscle. This pair of electrodes was either used for recording during the measurement of the effective refractory period in Purkinje fibers or for direct stimulation of the fibers. Glass microelectrodes, filled with 3 M KCl, were used to record transmembrane voltages from ventricular muscle (4) and from a nearby Purkinje fiber (3) . The distance between microelectrode sites (3) and (4) ranged from 1.5 to 4.0 mm. ventricular muscle attached at each end (Fig. 1) . After dissection, the preparations were stored in cool oxygenated Tyrode solution until studied. Tyrode solution, gassed with 95% oxygen, 5% carbon dioxide, was infused into the perfusion chamber at constant rates of 8 ml/min. Temperature was maintained at 36 ±10C. The composition of the Tyrode solution and the techniques used for stimulating and recording have been described previously (19, 22 In most experiments, the preparations were arranged as shown in Fig. 1 . The surface electrodes at site (1) were used to stimulate the ventricular muscle. The transmembrane potential of a nearby ventricular muscle cell was recorded using a microelectrode at site (4) . A simultaneous recording of the action potential of an adjacent Purkinje fiber and its first time derivative was made through a second microelectrode at site (3) . A pair of surface electrodes, placed on the Purkinje fiber (2), was used either to determine whether very premature action potentials propagated down the fiber from site (3) or to stimulate the Purkinje fiber directly during determination of the refractory period of ventricular muscle by the method of Kao and Hoffman (23) .
This arrangement was used to determine the effective refractory period (ERP) of ventricular muscle and Purkinje fibers and the "membrane responsiveness" of the Purkinje fiber. The preparation was stimulated at a basic drive cycle length of 800 msec (75/min) and premature stimuli were then introduced every seventh drive cycle through surface electrodes at site (1) . Action potentials were recorded at sites (3) and (4) (Fig. 1) (2) (Fig. 1) . Test stimuli then were made more premature until the ventricular muscle cell, impaled at site (4) (Fig. 1 shortening occurred without this change in shape (see Fig. 6 ). The marked effects on action potential duration (APD) and configuration were reversible within 20-60 min after removing lidocaine from the perfusate. The effect of lidocaine on PF APD was examined over a wide range of drive cycle lengths; the results obtained in 12 experiments are plotted in Fig. 4 . The absolute shortening in APD was greater at longer drive cycle lengths, but there was little difference in the per cent change at any given cycle length. For example, at a concentration of 1 X 10' mole/liter, APD decreased by 15 +3% at every drive cycle length. Fig. 4 also demonstrates the tendency for PF APD to be longer at a lidocaine concentration of 1 X 10-' mole/liter than CL 1000 at lower concentrations. This increase in duration was usually due to prolonged terminal repolarization which resulted from a decrease in slope (dv/dt) of repolarization as membrane potential approached DTMVmax (see Fig. 3 ).
In Fig. 5 , the PF APD for 15 fibers is plotted as a function of lidocaine concentration at a drive cycle length of 800 msec. The APD in PF shortened from a mean of 352 ±12 msec under control conditions to 325 ±12 msec after exposure to 1 X 10-7 M lidocaine (P < 0.05) and reached a minimum of 298 ±9 msec at a 1 X 10-' M lidocaine concentration (P < 0.001). At a 1 X 10-' M concentration of lidocaine, the mean APD was 306 ±12 msec, longer than at 5 X 10-' mole/liter, but CL 800 ventricular muscle fibers (below, unfilled symbols) as a function of the driven cycle length. Observations are shown for control conditions (circles), and during exposure to lidocaine at concentrations of 1 X 10' mole/liter (squares) and 1 X 10' mole/liter (triangles). APD of both PF and ventricular muscle (VM) fibers were recorded at drive cycle lengths of 400, 500, 800, 1000, and 2000 msec. After exposure to 1 X 10' M lidocaine, the PF APD shortened significantly at each drive rate (P < 0.001, at every cycle length). After exposure to a toxic concentration of lidocaine (1 X 10' mole/ liter), the mean APD became longer than that seen at a concentration of 1 X 10' mole/liter but was still significantly shorter than the APD recorded under control conditions (P <0.01, at every cycle length). VM fiber APD also shortened significantly (P < 0.001) at the 1 X 10' concentration. At a 1 X 10' M concentration, however, the VM APD is significantly shorter than control only at drive cycle lengths of 800 msec or longer (P < 0.05). overshoot to 16.8 +0.61 mv (P <0.001). Two muscle fibers studied at 1 X 10-' mole/liter and four of five studied at 5 X 10-' mole/liter showed large decreases in resting voltage and action potential amplitude with fragmentation of phase 0 depolarization into two components (see Fig. 6 ).
The action potential duration of ventricular muscle fibers was also shortened by lidocaine. When the preparation shown in Fig. 6 was driven at a cycle length of 1000 msec, the action potential in VM shortened by 36 msec during exposure to 1 X 10' M lidocaine (a decrease of 18%) and by 22 msec at 1 X 10' mole/liter (a decrease of 11% from control).
Shortening of APD after lidocaine also varied as a function of drive cycle length in all seven ventricular muscle fibers studied (see Figs. 4 and 6 ). Action potentials shortened more at longer cycle lengths where the control APD was longer, but the per cent change in APD at each cycle length again was virtually identical at any given lidocaine concentration. For instance, at 1 X 10' mole/liter, the mean per cent shortening from control, at the five stimulation cycle lengths shown in Fig. 4 , ranged from -22.4 ±3.3% to -27.0 ±3.0% (in each case, P < 0.001). It is also apparent in Fig. 4 that, at a concentration of 1 X 10' mole/liter, the APD at any given drive cycle length was longer than it had been at 1 X 10' mole/liter. This lengthening of APD at the 1 X 10-' M concentration was much more prominent in VM than in PF.
In Fig. 5 , VM APD is plotted as a function of lidocaine concentration for eight fibers stimulated at a constant 800 msec cycle length. No significant change from the control value of 183 ±10 msec was noted at a 1 X 10-7 M concentration. At 1 X 10' mole/liter, the mean shortening of 39.9 +4.3 msec (a 22% decrease) was highly significant ( P < 0.001). Fig. 5 ).
The PF ERP is plotted as a function of lidocaine concentration for all experiments in Fig. 8 The stimulating and recording arrangement used is shown in Fig. 1 . In each panel, the upper trace records time marks every 100 msec. The remaining three traces record the VM and PF action potentials (from sites 3 and 4, Fig. 1 ) and the PF surface electrogram (site 2, Fig. 1 ). The upper row of panels shows the most premature VM action potential obtainable (recorded at site 4, Fig. 1 Although the Purkinje fiber shown in Fig. 7 had an ERP shorter than control at both 5 x 10' and 1 X 10-' M lidocaine concentrations, the transmembrane voltage at which the most premature propagating response could be elicited was increased after application of lidocaine. Note that in Fig. 7 , transmembrane voltage at the time of earliest premature activation was 69 mv under control conditions, 75 mv during exposure to lidocaine 5 X 10' mole/liter, and 78 mv at 1 X 10-' mole/liter.
Thus the action potential shortened more than the ERP at these lidocaine concentrations (see Fig. 9 A) . These very premature responses were only elicited at higher transmembrane voltages and therefore had higher amplitudes than the early premature responses before lidocaine. The changes at 5 X 10-' mole/liter were not accompanied by a reduction in membrane responsiveness (vide infra).
Ventricular muscle. The effect of lidocaine on the ERP of ventricular muscle, measured in the same eight experiments, was qualitatively similar to the findings for Purkinje fibers. The upper row of panels in Fig. 7 shows that exposure to 5 X 10' M lidocaine shortened VM ERP by 31 msec. However, at 1 X 10-' mole/liter the VM ERP was not only longer than that found at 5 X 10' mole/liter but also exceeded the control value. (24) . Unfilled circles are experimental points obtained under control conditions. Filled circles are observations made after the fiber has been exposed to a 1 X 10' M lidocaine concentration. At this concentration, the relationship was not greatly altered, although the peak Vmax was increased and the curve relating Vmax to MP was steeper. At a 5 X104 M lidocaine concentration (filled triangles), the peak V.max was depressed in this fiber and the curve shifted to the right and downward. A further increase in lidocaine concentration to 1 X 10-' mole/liter resulted in further depression of peak Vm.z and further rightward shift in the curve. See text for further discussion. (B) The reversibility of lidocaine-induced depression of "membrane responsiveness" in Purkinje fiber. These observations were made in the same cell from which data was shown in part A. The control observations (unfilled circles), the observations made after 1 X 10' M lidocaine (toxic) (unfilled squares), and the computed curve have been replotted. After the measurements were made during exposure to 1 X 10' M lidocaine, the fiber was perfused with drug-free Tyrode solution. Measurements were made 1 hr later (filled circles). The severe depression of membrane responsiveness induced by lidocaine was reversed completely. cycle length 800 msec. At concentrations of 1 x 10-7 and 1 X 106 mole/liter, there was essentially no change from control in the peak V.ax. At 1 X 10' mole/liter, mean peak \ max increased to 551 ±12 v/sec which was not statistically significant (P < 0.1). There was no decrease in the peak V\ma in any fiber studied until lidocaine in the Tyrode solution reached a concentration of 5 X 10' mole/liter. The decrease in peak V.a. seen at 5 X 10-' mole/liter in some fibers (see Fig. 10 A) was not accompanied by a decrease in the transmembrane voltage of the Purkinje fiber. Although the peak Vmax fell in some fibers at the 5 X 10-M concentration and the mean peak Vrax fell to 491 ±17 v/sec (P < 0.05), it was only at 1 X 10' mole/liter that the mean peak Vmax for the group of fibers became impressively lower than control, 404 ±25 v/sec (P <0.001).
To Fig. 10A ). Under control conditions, the usual S-shaped relationship between lvmax and MAV (membrane responsiveness), first described for Purkinje fibers by Weidmann (24) Fig. 10 A) . Concentrations of 5 X 10' mole/liter produced variable effects on the relationship; in some fibers, no effect was seen, in others, a decrease in the peak Vmax occurred and the curve shifted slightly downward and to the right (see Fig. 10 A) . Lidocaine, in concentrations of 1 X 10' mole/liter or greater, invariably caused significant decreases in the peak Vmax and a pronounced downward and rightward shift of the curve (see Fig. 10 A and B (24) , rarely changed at a concentration of 5 X 10' mole/liter and never occurred at lower concentrations. However as previously indicated, the transmembrane voltage at which Purkinje fiber activation was first possible became progressively higher (more negative) with increases in concentration over the range of 1 X 10' to 5 X 10' mole/liter (see Fig. 7 ); in effect, the tail of the S-shaped curve was lost (see Fig. 10 A) . During exposure to these concentrations, the Vnmax was appropriate to the MAV over the entire transmembrane voltage range at which the fibers could be activated; at 1 X 10' mole/liter, some fibers even showed a higher Vmaz at a given MAV than under control conditions. It is this loss of the tail of the S-shaped curve that can allow the effective refractory period to become long relative to action potential duration without shifts in peak Vrmax or the steep portion of the curve on the voltage axis.
Five preparations which showed depressed membrane responsiveness after 30 min exposure to toxic concentrations of lidocaine (. 1 X 10' mole/liter) were subsequently perfused with normal Tyrode solution. Membrane responsiveness was restored to normal in each fiber within an hour after removing lidocaine from the Tyrode solution. (see Fig. 10 B) .
Effects of lidocaine on automaticity in Purkinje fibers
The effects of lidocaine on automaticity was examined in six spontaneously beating Purkinje fibers. A concentration of 1 X 10' mole/liter usually exerted a discernable negative effect. A concentration of 1 X 10' mole/ liter invariably caused slowing of spontaneously beating fibers by slowing the rate of phase 4 depolarization (see Fig. 11, panels A and B) . This concentration often caused cessation of spontaneous firing in pacemaker cells (see Fig. 11 , panel C) without causing a decrease in diastolic transmembrane voltage. The time course of this antiautomatic effect was rapid, and full effect was usually established in 10-15 min after initiating lidocaine perfusion. When 1 X 10' M lidocaine abolished automaticity in Purkinje fibers, neither diastolic excitability nor such electrophysiological characteristics as maximum diastolic voltage, amplitude, or overshoot were significantly affected (see Fig. 11, panel D) . The effect of lidocaine on epinephrine-induced arrhythmia or automaticity was examined in four preparations. Before lidocaine, transient exposure to high concentrations of epinephrine caused rapid spontaneous firing in Purkinje fibers (see Fig. 12 ). After lidocaine (1 X 10' mole/liter), higher concentrations of epinephrine were required to increase the spontaneous firing rate a smaller amount.
It is worth emphasizing that lidocaine exerted these powerful effects on automaticity and spontaneous firing of Purkinje fibers at concentrations (1 X 10-and 1 X 10-mole/liter) which had no significant effect on the maximum diastolic voltage, amplitude, overshoot, or peak Vra. of the Purkinje fiber action potential. Other than decreased automaticity, the only consistent effect of lidocaine at these concentrations was shortening of action potential and effective refractory period duration. DISCUSSION The results of these experiments caused us to reject the hypothesis that lidocaine exerts electrophysiological effects essentially like those of procaine amide or quinidine on canine Purkinje and ventricular muscle cells. Procaine amide and quinidine possess local anesthetic properties and are known to: (a) enhance automaticity in high concentrations, (b) prolong the duration of the action potential and the effective refractory period in both Purkinje and ventricular muscle fibers, and (c) to decrease the membrane responsiveness of Purkinje fibers in low to moderate concentrations, thereby decreasing conduction velocity (21) . In this study, lidocaine: (a) never induced automaticity in Purkinje fibers, even those exposed to concentrations as extreme as 5 X 10' mole/liter, (b) decreased both action potential duration and effective refractory period in Lidocaine did share with procaine amide and quinidine two properties: (a) suppression of automaticity in Purkinje fibers and (b) a characteristic alteration in the relationship between action potential duration and effective refractory period in both Purkinje and ventricular muscle fibers. Lidocaine suppressed automaticity in Purkinje fibers, predominantly by altering phase 4 depolarization; this anti-automatic effect was present even at low concentrations (e.g. 1 X 10 mole/liter) and showed a concentration-dependent increase in both rapidity of onset and extent of suppression. Although lidocaine decreased the duration of both the action potential and effective refractory period of Purkinje and ventricular muscle fibers, shortening of action potential duration was greater than shortening in the effective refractory period (see Fig. 8 ). Thus, the relationship between full recovery of repolarization and recovery of excitability was altered in the same direction by lidocaine as by procaine amide and quinidine, although absolute changes in these two variables were opposite in direction.
The differences in electrophysiological properties between lidocaine and procaine amide or quinidine are particularly interesting when one considers the structural similarities of lidocaine and procaine amide. Although the local anesthetics are often discussed as if they had uniform properties, the literature reveals that differences between individual local anesthetics have often been appreciated when two or more local anesthetics have been examined in a given biological system (25) (26) (27) (28) . Quantitative differences among the local anesthetics have been explained by differences in pKa. Differences in pKa determine differences in the ratio of free base ( B ) to cationic form (BH+) between the various compounds at physiological pH. Whether a particular local anesthetic exists as B or in the form BH+ determines, in large part, how well the drug crosses cell membranes and the intensity of its pharmacological effect (28, 29) . For instance, the B: BH+ has been shown to be important in determining local anesthetic potency in producing peripheral nerve block (29, 30) . The pKa of lidocaine is 7.85 (30), a value considerably lower than any other commonly used local anesthetic. This means, for example, that at pH 7.36 (the pH of the Tyrode solution in our experiments) lidocaine has a B: BH+ nearly 10 times that of procaine with its pKa of 8.95. The low pKa of lidocaine relative to other local anesthetics also means that its B: BH+ is more responsive to changes of pH in the physiological range. However, the qualitative nature of the differences between lidocaine and procaine amide could not be explained by differences in the B: BH+ due to differences in pKa.
After studying the effects produced by a wide range of lidocaine concentrations, we feel that the effects seen at 1 X 10-mole/liter (2.34 tig/ml) correspond to the effects produced by therapeutic concentrations (2) (3) (4) (5) ,ug/ml) in man (6) . Certainly, the concentration corresponding to therapeutic levels in man must be less than 1 x 10' mole/liter since this concentration had effects which would produce widening of the QRS complex of the electrocardiogram in vivo; full antiarrhythmic doses of lidocaine do not cause widening of the QRS complex in man (13) . We have therefore used the effects produced by the 1 X 10' M concentration in proposing how lidocaine might exert its antiarrhythmic effect in vivo. It is interesting that the antiarrhythmic lidocaine plasma concentration of 2-5 Ag/ml in man (6) is so similar to the in vitro concentration thought to produce comparable effects. We recognize the fact that many difficulties are encountered in attempts to relate in vivo plasma concentrations to the concentration of drugs perfusing isolated preparations of cardiac tissue (22) . The similarity between the effective in vitro and in vivo concentrations may be due, in part, to the fact that lidocaine, unlike procaine amide or quinidine, is not significantly bound to plasma proteins (30) (31) (32) and diffuses readily into the tissues (25, 30) .
Having identified such substantial differences between lidocaine and the standard antiarrhythmic drugs, procaine amide and quinidine, we will propose mechanisms by which lidocaine might exert its clinical antiarrhythmic effects. Hoffman has proposed that arrhythmias may be produced by: (a) enhanced automaticity, (b) depressed conductivity, or (c) combinations of enhanced automaticity and depressed conductivity (18, 33) . Clinical ventricular arrhythmias caused by either widespread or local areas of enhanced automaticity in the HisPurkinje system should be abolished by lidocaine treatment, since low concentrations suppress automaticity induced by a variety of causes.
Depressed conductivity can lead to arrhythmias by allowing reentry to occur in focal areas which have the appropriate geometrical arrangement and functional properties. The simple model often utilized to explain ventricular reentrant rhythms is a Purkinje fiber which divides into two branches which almost immediately terminate on a strip on ventricular muscle (18) . One branch must demonstrate unidirectional block so that, if conduction velocities and refractory periods in the component tissues are appropriate, impulses can reenter the circuit one or more times, leading to single premature beats or runs of "ectopic rhythm."
On the basis of observations made in this study, lidocaine could abolish such reentrant ventricular arrhythmias by altering conductivity in at least two ways. First, beneficial alterations in conductivity in a reentrant circuit might result from the lengthening of the effective refractory period relative to action potential duration in either Purkinje or ventricular muscle fibers. The change in the relationship between these two variables occurs. at "therapeutic" drug concentrations where membrane responsiveness is not diminished, but premature stimuli are unable to activate the fiber until higher transmembrane voltages are reached; this effect would cause early recirculating impulses to be completely blocked. When the fiber has repolarized to a voltage sufficient: for activation in the presence of lidocaine, Vm.. would.
be unaltered or improved from predrug values at any given MAV; conduction might therefore become incremental. i.e., increase in velocity with each unit of space traversed. The opportunity to utilize this antiarrhythmic mechanism might be provided by the decrease that lidocaine produces in Purkinje and ventricular muscle fiber action potential duration and the fact that the decrease is relatively greater in Purkinje fibers. Therefore, if conduction time in the reentry circuit, in response to application of lidocaine, initially remained constant, the Purkinje fiber would repolarize to higher transmembrane voltages before the arrival of the recirculating impulse, so that MAV and Vmar would increase, thus leading to an increment in the mean conduction velocity in the reentrant pathway. This would lead to a decrease in wavelength in the pathway and could extinguish the arrhythmia.
A second mechanism by which lidocaine could interrupt reentry circuits would be by improving membrane responsiveness and thereby improve conduction in the Purkinje fiber branch showing slowed conduction. Even if conduction in the depressed branch of the Purkinje fiber did not become normal but only improved enough to allow the impulse to penetrate further toward ventricular muscle or to be sustained for a longer time before blocking, reentry from ventricular muscle into the depressed branch would be prevented (34) . Our results make this hypothesis tenable. Lidocaine is capable of shifting the curve relating V.ma to MAV upward and leftward (see Fig. 10 A) . An increase in VVmax would lead to improved conduction (24, 35) . Such an improvement in membrane responsiveness would produce -particularly marked improvement in conduction in tissues having low transmembrane voltages (e.g. the depressed branch of the reentry model).
In many clinical arrhythmias, both decreased conduc--tivity and increased automaticity may play a role (33) . Indeed, enhanced automaticity itself may lead to depressed conductivity. Amplitude and V.a. of action -potentials evoked in Purkinje fibers are, for practical -purposes, entirely dependent on membrane voltage at the time of activation (24) , no matter whether a given membrane voltage has been reached: (a) during repolarization of a normal action potential, (b) by generalized depolarization of the membrane, or (c) by phase 4 depolarization. Augmented automaticity localized -to one branch of a Purkinje fiber could cause delayed Londuction and block of impulses propagating into this branch; this conduction delay can be unidirectional and -cause reentry (20) . Application of lidocaine could diminish automaticity and thereby speed conduction and abolish reentry. Thus, lidocaine potentially has the ca--pacity to favorably alter ventricular arrhythmias arising from any of the three general mechanisms proposed by Hoffman (18) .
We have no direct evidence on the alterations of ionic mechanisms which mediate the profound changes in action potential depolarization and repolarization produced by lidocaine. However, in concentrations equivalent to therapeutic concentrations in man, lidocaine never -decreases membrane responsiveness, suggesting that the availability of the sodium carrier is not reduced by these -concentrations (24) . Toxic concentrations, > 1 X 10' mole/liter, rapidly and significantly decreased membrane responsiveness indicating partial inactivation of the sodium carrier. High concentrations of local anesthetics produce a similar effect on squid axon (36) . In addition, lidocaine had marked effects on repolarization in both Purkinje and ventricular muscle fibers, even at low concentrations. Lidocaine-induced shortening of the action potential is clearly attributable to shortening of phase 2 repolarization in Purkinje fibers.
The abbreviated repolarization could be due to: (a) development of or increase in an inward current carried by negatively charged ions, e.g. C1-, (b) an increase in an outward current-carried by positively charged ions, e.g. K+, (c) a decrease in an inward current carried by positive ions, e.g. Na+ or Ca+', or (d) a decrease in an outward current carried by negative ions, e.g., Cl-. Since the ionic currents which flow when Purkinje fiber transmembrane voltage is clamped at plateau levels (> -20 mv) are complicated and disputed (37) (38) (39) (40) (41) , selection of the ionic species mediating lidocaine's effect on repolarization is difficult. Nevertheless, the fact that lidocaine shortens ventricular muscle and Purkinje fiber action potentials at concentrations where its only other prominent effect is to suppress automaticity suggests that the ion primarily involved may be potassium. Increased sarcolemmal permeability to K+ throughout the cardiac cycle would both accelerate repolarization and suppress automaticity. Lidocaine's shortening of action potential phase 2 could also be exerted by premature initiation of the increase in potassium conductance during repolarization. Lidocaine has a high affinity for phospholipids in the lipid layer of nerve and muscle cell membranes (42) . By combining with sarcolemmal lipids, lidocaine could conceivably alter the number, size, or geometry of the potassium channels and lead to the observed changes in repolarization and phase 4 depolarization. However, the time course and amount of membrane current carried by K+ during Purkinje fiber repolarization remains controversial and information about these events in mammalian ventricular muscle is lacking (38, 41, 43) . The potassium conductance of Purkinje fiber membrane during the cardiac cycle can be resolved into at least two components possessing markedly different functional characteristics (43, 44) ; one is voltage dependent, activated near plateau voltage levels and probably responsible, in large part, for repolarization of Purkinje fibers, while the second is time dependent, responsible for the very small currents existing after full repolarization and may be related to phase 4 depolarization. Therefore, our proposal of one change in the ionic events to explain both accelerated repolarization and suppressed phase 4 depolarization is probably greatly oversimplified.
